Detalles de la búsqueda
1.
A phase II clinical and pharmacodynamic study of E7070 in patients with metastatic, recurrent, or refractory squamous cell carcinoma of the head and neck: modulation of retinoblastoma protein phosphorylation by a novel chloroindolyl sulfonamide cell cycle inhibitor.
Clin Cancer Res
; 10(14): 4680-7, 2004 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15269140
Resultados
1 -
1
de 1
1
Próxima >
>>